1. Home
  2. AQST vs KBSX Comparison

AQST vs KBSX Comparison

Compare AQST & KBSX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • AQST
  • KBSX
  • Stock Information
  • Founded
  • AQST 2004
  • KBSX 1976
  • Country
  • AQST United States
  • KBSX Taiwan
  • Employees
  • AQST N/A
  • KBSX N/A
  • Industry
  • AQST Biotechnology: Pharmaceutical Preparations
  • KBSX Recreational Games/Products/Toys
  • Sector
  • AQST Health Care
  • KBSX Consumer Discretionary
  • Exchange
  • AQST Nasdaq
  • KBSX Nasdaq
  • Market Cap
  • AQST 254.1M
  • KBSX 299.4M
  • IPO Year
  • AQST 2018
  • KBSX N/A
  • Fundamental
  • Price
  • AQST $2.51
  • KBSX $2.15
  • Analyst Decision
  • AQST Strong Buy
  • KBSX
  • Analyst Count
  • AQST 6
  • KBSX 0
  • Target Price
  • AQST $11.17
  • KBSX N/A
  • AVG Volume (30 Days)
  • AQST 1.4M
  • KBSX 520.0K
  • Earning Date
  • AQST 05-06-2025
  • KBSX 04-25-2025
  • Dividend Yield
  • AQST N/A
  • KBSX N/A
  • EPS Growth
  • AQST N/A
  • KBSX N/A
  • EPS
  • AQST N/A
  • KBSX N/A
  • Revenue
  • AQST $57,561,000.00
  • KBSX $33,935,076.00
  • Revenue This Year
  • AQST N/A
  • KBSX N/A
  • Revenue Next Year
  • AQST $39.51
  • KBSX N/A
  • P/E Ratio
  • AQST N/A
  • KBSX N/A
  • Revenue Growth
  • AQST 13.79
  • KBSX N/A
  • 52 Week Low
  • AQST $2.20
  • KBSX $1.26
  • 52 Week High
  • AQST $5.80
  • KBSX $15.48
  • Technical
  • Relative Strength Index (RSI)
  • AQST 41.88
  • KBSX N/A
  • Support Level
  • AQST $2.20
  • KBSX N/A
  • Resistance Level
  • AQST $2.61
  • KBSX N/A
  • Average True Range (ATR)
  • AQST 0.22
  • KBSX 0.00
  • MACD
  • AQST -0.03
  • KBSX 0.00
  • Stochastic Oscillator
  • AQST 36.47
  • KBSX 0.00

About AQST Aquestive Therapeutics Inc.

Aquestive Therapeutics Inc is a specialty pharmaceutical company engaged in developing and commercializing differentiated products to meet medical needs. Its later-stage product pipeline focuses on the treatment of diseases of the Central Nervous System (CNS), and an earlier-stage pipeline for the treatment of severe allergic reactions, including anaphylaxis. Its commercial product portfolio includes Suboxone, Emylif, Ondif and Sympazan. The product pipeline includes Libervant Buccal Film, AQST-108. The majority of its revenue comes from the United States.

About KBSX FST Corp. Ordinary Shares

FST Corp is a renowned manufacturer and innovator in the golf industry with a growing portfolio of creative golf products, including acclaimed golf club shafts and other equipment. The Company has engaged in the research, development, manufacturing, and sales of golf club shafts. The Company currently produces and sells golf club shafts under the Company's own high-performance KBS golf club shaft brand, and serves as an original equipment manufacturer (OEM) and original design manufacturer (ODM) for other world-renowned golf equipment brands, golf equipment OEMs, and golf equipment distributors that provide consumers with customized golf club services.

Share on Social Networks: